Gu Y, Bartolom-Casado R, Xu C, Bertocchi A, Janney A, Heuberger C, et al
Abstract Introduction: With the rise in glucagon-like peptide 1 receptor agonist (GLP-1RA) medication usage for Type 2 diabetes mellitus and weight loss, concerns have been raised regarding safety and primary aspiration risk when undergoing anesthesia procedures
Even missing a single dose can affect how well the drugs work, and it may increase the risk of side effects
Currently enrolled in phase 2 clinical trials, MariTide is expected to conclude by late 2024, with future studies in phase 3 focusing on obesity and its associated conditions, including heart, liver, and kidney diseases
2-Month Supply: Each bottle contains 60 servings, providing 2 months of supply
This can come from contact with your bacteria-filled phone screen